Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$819M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$550M |
| 3 |
Boston Scientific
BSX
|
+$303M |
| 4 |
ExxonMobil
XOM
|
+$291M |
| 5 |
Advanced Micro Devices
AMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$513M |
| 2 |
Apple
AAPL
|
+$396M |
| 3 |
Target
TGT
|
+$379M |
| 4 |
Eli Lilly
LLY
|
+$351M |
| 5 |
EOG Resources
EOG
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.82% |
| 2 | Healthcare | 12.74% |
| 3 | Financials | 11.16% |
| 4 | Industrials | 8.55% |
| 5 | Consumer Discretionary | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
LifeMD
LFMD
$176M
| $92K | ﹤0.01% |
44,960
-30
| -0.1% | -$75 |
|
|
RAD
3727
DELISTED
Rite Aid Corporation
RAD
| $91K | ﹤0.01% |
13,510
-7,595
| -36% | -$50.3K |
|
|
USER
3728
DELISTED
UserTesting, Inc.
USER
| $90K | ﹤0.01% |
+17,855
| New | +$120K |
|
3729
Harmony Gold Mining
HMY
$10.1B
| $89K | ﹤0.01% |
28,461
-548
| -2% | -$2.11K |
|
3730
Oramed Pharmaceuticals
ORMP
$169M
| $89K | ﹤0.01% |
19,525
-12,975
| -40% | -$69.3K |
|
3731
NexGen Energy
NXE
$6.17B
| $88K | ﹤0.01% |
24,481
-2,700
| -10% | -$12.8K |
|
|
CHMI
3732
Cherry Hill Mortgage Investment Corp
CHMI
$82.7M
| $87K | ﹤0.01% |
13,504
+2,640
| +24% | +$18.2K |
|
3733
Safe Bulkers
SB
$810M
| $86K | ﹤0.01% |
+22,565
| New | +$96.3K |
|
|
AMRS
3734
DELISTED
Amyris Inc.
AMRS
| $86K | ﹤0.01% |
46,418
-21,724
| -32% | -$63.9K |
|
3735
Amneal Pharmaceuticals
AMRX
$5.91B
| $85K | ﹤0.01% |
26,652
+9,436
| +55% | +$34.2K |
|
3736
CEL-SCI Corp
CVM
$21.3M
| $82K | ﹤0.01% |
607
-80
| -12% | -$8.33K |
|
3737
FuelCell Energy
FCEL
$1.89B
| $80K | ﹤0.01% |
707
-6,901
| -91% | -$870K |
|
3738
Garrett Motion
GTX
$5.78B
| $78K | ﹤0.01% |
+10,133
| New | +$68.6K |
|
3739
Graham Corp
GHM
$1.1B
| $76K | ﹤0.01% |
11,000
| – | – |
|
|
NAGE
3740
Niagen Bioscience
NAGE
$264M
| $76K | ﹤0.01% |
45,684
-5,015
| -10% | -$9.81K |
|
3741
iQIYI
IQ
$1.24B
| $75K | ﹤0.01% |
18,030
+5,178
| +40% | +$20.8K |
|
3742
Rhythm Pharmaceuticals
RYTM
$7.25B
| $75K | ﹤0.01% |
+18,140
| New | +$99.3K |
|
|
HUYA
3743
Huya Inc
HUYA
$570M
| $74K | ﹤0.01% |
19,029
-7,909
| -29% | -$33K |
|
|
NVTA
3744
DELISTED
Invitae Corporation
NVTA
| $72K | ﹤0.01% |
29,583
+8,040
| +37% | +$35.6K |
|
|
PNNT
3745
Pennant Park Investment Corp
PNNT
$217M
| $68K | ﹤0.01% |
+11,011
| New | +$78.4K |
|
|
CBAY
3746
DELISTED
Cymabay Therapeutics
CBAY
| $66K | ﹤0.01% |
22,261
-1,400
| -6% | -$3.34K |
|
3747
MediciNova
MNOV
$66M
| $65K | ﹤0.01% |
25,500
-1,700
| -6% | -$4.44K |
|
3748
Lineage Cell Therapeutics
LCTX
$277M
| $64K | ﹤0.01% |
+40,660
| New | +$53.6K |
|
3749
FuboTV Inc
FUBO
$253M
| $63K | ﹤0.01% |
2,117
-203
| -9% | -$9.46K |
|
|
MOMO
3750
Hello Group
MOMO
$886M
| $62K | ﹤0.01% |
12,305
-22,545
| -65% | -$118K |
|
Similar funds
Ameriprise's Q2 2022 Portfolio in Review
As of Q2 2022, Ameriprise held 4,071 positions worth $287B, down 15% from $339B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Ameriprise's Q2 2022 filing shows 137 new, 1,635 increased, 1,970 reduced and 191 closed positions. Its largest new stake was Aspen Technology Inc: 409,068 shares worth $75.1M. The largest sale was Medtronic, an estimated $513M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q2 2022 buy was Aspen Technology Inc: 409,068 shares worth $75.1M.
- Ameriprise added most to Wells Fargo in Q2 2022, an estimated $819M increase.
- Ameriprise's biggest Q2 2022 reduction was Medtronic, cutting an estimated $513M.
- Ameriprise fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $250M.
- Ameriprise's ten largest holdings make up 14% of its $287B portfolio in Q2 2022.
- Ameriprise opened 137 new positions and closed 191 in Q2 2022.
- Ameriprise's portfolio value fell 15% quarter-over-quarter to $287B.
Based on Ameriprise's 13F filing for Q2 2022, filed 15 Aug 2022.